Verition Fund Management LLC - SYNTA PHARMACEUTICALS CORP ownership

Back to all holdings Add to watchlist

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.

Links
Filings
External links
Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$63,000
+90.9%
28,261
+130.4%
0.01%
+57.1%
Q4 2014$33,000
-45.0%
12,266
-38.0%
0.01%
-12.5%
Q3 2014$60,000
+9.1%
19,785
+79.2%
0.01%
-20.0%
Q2 2013$55,000–11,043–0.01%–
 Download
Other shareholders

There were no reported owners of SYNTA PHARMACEUTICALS CORP in Q2 2015.

NameSharesValueWeighting ↓
View complete list of SYNTA PHARMACEUTICALS CORP shareholders